Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Calcineurin helps newborns breathe easy
Slashdot It! Slashdot Calcineurin helps newborns breathe easy
Submit to Reddit Submit Calcineurin helps newborns breathe easy to Reddit
Reading: Calcineurin helps newborns breathe easyTwitter This Reading: Calcineurin helps newborns breathe easyTwitter Calcineurin helps newborns breathe easy
Add to Facebook Add Calcineurin helps newborns breathe easy to Facebook

Calcineurin helps newborns breathe easy

September 22, 2006

It is only very late in pregnancy that the lungs of the fetus complete their development so that the fetus will be able to breathe air when it is born. As a result, many premature babies suffer from the potentially life threatening respiratory distress syndrome. The proteins that control the final stages of lung development have not been identified.

Now, in a study appearing online on September 21, in advance of publication in the October print issue of the Journal of Clinical Investigation, Vrushank Davé and colleagues from the University of Cincinnati, show that in mice a protein known as calcineurin is essential for complete lung development.




Mice lacking calcineurin function in the epithelial cells of the lung were unable to breathe properly and died shortly after birth because their lungs failed to develop fully. These effects of calcineurin were mediated by a protein known as NFATc3, which was shown to activate the expression of many of the genes that need to be activated if the final stages of lung development are to proceed normally.

This study describes one pathway controlling the final stages of lung development in mice and might help researchers design strategies to treat respiratory distress syndrome in premature babies.

Journal of Clinical Investigation





Science News and Science Current Events Tag Cloud
This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size.
Epstein-barr Virus   Hydrothermal Vents   Lung Cancer   Wireless   Tooth Loss   Endometriosis   Amazon rainforest   Blood Thinner   Health Care   Cancer Diagnosis   Shade Trees   Seizures   Hysterectomy   Coronary Artery Disease   Drosophila   Secondhand Smoke   Ozone Hole   Renewable energy   Computer Model   Aspirin   Snowmelt   Urinary Tract Infection   Nanomaterial   Medulloblastoma   Stomach Cancer  
Related Calcineurin Current Events and Calcineurin News Articles Calcineurin Current Events and Calcineurin News RSS Calcineurin Current Events and Calcineurin News RSS
Why do people with Down syndrome have less cancer?
Most cancers are rare in people with Down syndrome, whose overall cancer mortality is below 10 percent of that in the general population.

New hope for treatment of neurodegenerative disorder
Researchers from the University of Southern California have taken an important first step toward protecting against Huntington disease using gene therapy.

Researchers discover link between organ transplantation and increased cancer risk
Researchers have determined a novel mechanism through which organ transplantation often leads to cancer, and their findings suggest that targeted therapies may reduce or prevent that risk.

Investigational drug tested for preventing muscle fiber death in muscular dystrophy
An investigational antiviral drug currently undergoing human trials in Europe for treating Hepatitis C infections may have potential to reduce muscle cell damage in Duchenne and other forms of muscular dystrophy (MD).

Mayo Clinic study finds heart transplant patients benefit from new approach to immunosuppression
A new immunosuppression regimen for heart transplant patients can improve kidney function and prevent transplant coronary artery disease, according to two new Mayo Clinic studies.

Mayo Clinic study finds heart transplant patients benefit from new approach to immunosuppression
A new immunosuppression regimen for heart transplant patients can improve kidney function and prevent transplant coronary artery disease, according to two new Mayo Clinic studies.

New type of rejection blocker protects kidneys after transplant
In an international clinical trial, a new drug that selectively blocks immune responses has proved as effective in preventing acute kidney transplant rejection as cyclosporine, the standard anti-rejection treatment.

Increasing the success of liver transplants by managing levels of anti-rejection drugs
Approximately 600 children receive liver transplants each year in the United States. The use of immunosuppressant drug therapy, namely calcineurin inhibitors (CNIs) such as cyclosporine and tacrolimus, has decreased the risk of liver rejection and increased patient survival rates.
More Calcineurin Current Events and Calcineurin News Articles
Effect of calcineurin inhibitors on myotoxic activity of crotoxin and Bothrops asper phospholipase A

Effect of calcineurin inhibitors on myotoxic activity of crotoxin and Bothrops asper phospholipase A"2 myotoxins in vivo and in vitro [An article from: Comparative Biochemistry and Physiology, Part C]
by E.H. Miyabara (Author), I.L. Baptista (Author), B. Lomonte (Author), Selistre (Author)

This digital document is a journal article from Comparative Biochemistry and Physiology, Part C, published by Elsevier in 2006. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.

Description:
Previous studies have shown that calcineurin activity plays a critical role in the myotoxic activity induced by crotoxin (CTX), a group II phospholipase A"2 (PLA"2) with neurotoxic and myotoxic actions. In order to address whether calcineurin is also important for the activity of non-neurotoxic group II PLA"2 myotoxins we have compared the effects of calcineurin inhibition on the myotoxic capacity of CTX and the non-neurotoxic PLA"2s, myotoxin II (Mt II) and myotoxin III (Mt III) from...

Calcium Homeostasis

Calcium Homeostasis
by Springer

This new "Topics" series is an "offspring" of our well established series "Structure and Bonding". The foundation of TBIC reflects the importance research has gained at the interface of inorganic and biological chemistry in the past years. Biological inorganic chemistry is a field of research at the interface of inorganic and biological chemistry. The rapidly developing insights into the role of metals in biological systems has far-reaching implications not only for biological science but also for related disciplines, ranging from molecular medicine to the environment. In each volume the reader, whether engaged in chemistry, biochemistry, biology or molecular medicine, receives a comprehensive summary and critical overview of a topic of high current interest written by leading...

  Calcineurin inhibitors offer advantages for eczema: tacrolimus, pimecrolimus.(Children's Health): An article from: Family Practice News
by Kate Johnson (Author)

This digital document is an article from Family Practice News, published by International Medical News Group on January 1, 2004. The length of the article is 862 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Calcineurin inhibitors offer advantages for eczema: tacrolimus, pimecrolimus.(Children's Health)
Author: Kate Johnson
Publication: Family Practice News (Magazine/Journal)
Date: January 1, 2004
Publisher: International Medical News Group
Volume: 34 Issue: 1 Page: 69(1)

Distributed by Thomson...

  Early data suggest calcineurin inhibitors are safe for infants: atopic dermatitis therapy.(Dermatologic Therapy)(pimecrolimus cream): An article from: Skin & Allergy News
by Sherry Boschert (Author)

This digital document is an article from Skin & Allergy News, published by International Medical News Group on February 1, 2004. The length of the article is 1157 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Early data suggest calcineurin inhibitors are safe for infants: atopic dermatitis therapy.(Dermatologic Therapy)(pimecrolimus cream)
Author: Sherry Boschert
Publication: Skin & Allergy News (Magazine/Journal)
Date: February 1, 2004
Publisher: International Medical News Group
Volume: 35 Issue: 2 Page: 28(1)

Distributed by Thomson...

  Topical calcineurin inhibitors can still be used in children.(Skin Disorders): An article from: Family Practice News
by Robert Finn (Author)

This digital document is an article from Family Practice News, published by Thomson Gale on October 15, 2005. The length of the article is 496 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Topical calcineurin inhibitors can still be used in children.(Skin Disorders)
Author: Robert Finn
Publication: Family Practice News (Magazine/Journal)
Date: October 15, 2005
Publisher: Thomson Gale
Volume: 35 Issue: 20 Page: 35(1)

Distributed by Thomson...

  Treating kids? Use topical calcineurin inhibitor with topical corticosteroid: for itching and burning.(Dermatologic Theraphy): An article from: Skin & Allergy News
by Robert Finn (Author)

This digital document is an article from Skin & Allergy News, published by International Medical News Group on August 1, 2003. The length of the article is 2581 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Treating kids? Use topical calcineurin inhibitor with topical corticosteroid: for itching and burning.(Dermatologic Theraphy)
Author: Robert Finn
Publication: Skin & Allergy News (Magazine/Journal)
Date: August 1, 2003
Publisher: International Medical News Group
Volume: 34 Issue: 8 Page: 24(1)

Distributed by Thomson...

  Calcineurin inhibitors may pose cancer risk in children: box warning needed.(Children's Health): An article from: Family Practice News
by Sally Koch Kubetin (Author)

This digital document is an article from Family Practice News, published by International Medical News Group on March 1, 2004. The length of the article is 894 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Calcineurin inhibitors may pose cancer risk in children: box warning needed.(Children's Health)
Author: Sally Koch Kubetin
Publication: Family Practice News (Magazine/Journal)
Date: March 1, 2004
Publisher: International Medical News Group
Volume: 34 Issue: 5 Page: 112(1)

Distributed by Thomson...

  Primary care cuts use of calcineurin inhibitors.(Skin Disorders)(treatments used by pediatric dermatologists evaluated): An article from: Family Practice News
by Bruce Jancin (Author)

This digital document is an article from Family Practice News, published by Thomson Gale on May 1, 2006. The length of the article is 986 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Primary care cuts use of calcineurin inhibitors.(Skin Disorders)(treatments used by pediatric dermatologists evaluated)
Author: Bruce Jancin
Publication: Family Practice News (Magazine/Journal)
Date: May 1, 2006
Publisher: Thomson Gale
Volume: 36 Issue: 9 Page: 27(1)

Distributed by Thomson...

  Panel assesses calcineurin inhibitors in children: FDA advisory panel.(Dermatologic Therapy): An article from: Skin & Allergy News
by Sally Koch Kubetin (Author)

This digital document is an article from Skin & Allergy News, published by International Medical News Group on December 1, 2003. The length of the article is 728 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Panel assesses calcineurin inhibitors in children: FDA advisory panel.(Dermatologic Therapy)
Author: Sally Koch Kubetin
Publication: Skin & Allergy News (Magazine/Journal)
Date: December 1, 2003
Publisher: International Medical News Group
Volume: 34 Issue: 12 Page: 18(1)

Distributed by Thomson...

  Box warning needed to correct calcineurin inhibitors misuse: FDA panel advisory.(Clinical Rounds): An article from: Pediatric News
b

This digital document is an article from Pediatric News, published by International Medical News Group on December 1, 2003. The length of the article is 562 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Box warning needed to correct calcineurin inhibitors misuse: FDA panel advisory.(Clinical Rounds)
Publication: Pediatric News (Magazine/Journal)
Date: December 1, 2003
Publisher: International Medical News Group
Volume: 37 Issue: 12 Page: 29(1)

Distributed by Thomson...

© 2009 BrightSurf.com